Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pixu Liu

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Cancer Science|January 30, 2024
Inhibition of palmitoyltransferase ZDHHC12 sensitizes ovarian cancer cells to cisplatin through ROS-mediated mechanismsXining Zhang, Xingming Liao, Min Wang, et al.
Redox Biology|May 29, 2019
Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancerMin Wang, Yijue Xue, Lanlin Shen, et al.
Materials Today. Bio|February 8, 2024
Mi-BMSCs alleviate inflammation and fibrosis in CCl<sub>4</sub>-and TAA-induced liver cirrhosis by inhibiting TGF-β/Smad signalingQing Shi, Yuhan Xia, Minmin Wu, et al.
American Journal of Respiratory Cell and Molecular Biology|February 21, 2024
Presenilin 1 Is a Therapeutic Target in Pulmonary Hypertension and Promotes Vascular RemodelingTingTing Shen, JiuCheng Shi, XiJuan Zhao, et al.
Oncotarget|February 25, 2016
Effective use of PI3K inhibitor BKM120 and PARP inhibitor Olaparib to treat PIK3CA mutant ovarian cancerDong Wang, Min Wang, Nan Jiang, et al.
Oncology Reports|March 22, 2019
Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylationZhen Xiao, Yingying He, Chongya Liu, et al.
Gynecologic Oncology|July 19, 2016
Combined inhibition of PI3K and PARP is effective in the treatment of ovarian cancer cells with wild-type PIK3CA genesDong Wang, Chengbo Li, Yuan Zhang, et al.
Oncotarget|April 25, 2015
High frequency of loss of PTEN expression in human solid salivary adenoid cystic carcinoma and its implication for targeted therapyHan Liu, Li Du, Ru Wang, et al.
Cell Reports|January 25, 2026
Targeting ZDHHC12-mediated PARP1 palmitoylation potentiates PARP inhibitor cytotoxicityXining Zhang, Ye Liu, Xingming Liao, et al.
Nature|January 28, 2016
Corrigendum: Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesisShidong Jia, Zhenning Liu, Sen Zhang, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Cancer Science|January 30, 2024
Inhibition of palmitoyltransferase ZDHHC12 sensitizes ovarian cancer cells to cisplatin through ROS-mediated mechanismsXining Zhang, Xingming Liao, Min Wang, et al.
Redox Biology|May 29, 2019
Inhibition of SGK1 confers vulnerability to redox dysregulation in cervical cancerMin Wang, Yijue Xue, Lanlin Shen, et al.
Materials Today. Bio|February 8, 2024
Mi-BMSCs alleviate inflammation and fibrosis in CCl<sub>4</sub>-and TAA-induced liver cirrhosis by inhibiting TGF-β/Smad signalingQing Shi, Yuhan Xia, Minmin Wu, et al.
American Journal of Respiratory Cell and Molecular Biology|February 21, 2024
Presenilin 1 Is a Therapeutic Target in Pulmonary Hypertension and Promotes Vascular RemodelingTingTing Shen, JiuCheng Shi, XiJuan Zhao, et al.
Oncotarget|February 25, 2016
Effective use of PI3K inhibitor BKM120 and PARP inhibitor Olaparib to treat PIK3CA mutant ovarian cancerDong Wang, Min Wang, Nan Jiang, et al.
Oncology Reports|March 22, 2019
Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylationZhen Xiao, Yingying He, Chongya Liu, et al.
Gynecologic Oncology|July 19, 2016
Combined inhibition of PI3K and PARP is effective in the treatment of ovarian cancer cells with wild-type PIK3CA genesDong Wang, Chengbo Li, Yuan Zhang, et al.
Oncotarget|April 25, 2015
High frequency of loss of PTEN expression in human solid salivary adenoid cystic carcinoma and its implication for targeted therapyHan Liu, Li Du, Ru Wang, et al.
Cell Reports|January 25, 2026
Targeting ZDHHC12-mediated PARP1 palmitoylation potentiates PARP inhibitor cytotoxicityXining Zhang, Ye Liu, Xingming Liao, et al.
Nature|January 28, 2016
Corrigendum: Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesisShidong Jia, Zhenning Liu, Sen Zhang, et al.
Pageof 5